Document is current
Any future updates will be listed below
-
Authors
Akbari, Parsa http://orcid.org/0000-0001-9210-4760
Vuckovic, Dragana
Stefanucci, Luca http://orcid.org/0000-0002-4352-1151
Jiang, Tao
Kundu, Kousik http://orcid.org/0000-0002-1019-8351
Kreuzhuber, Roman http://orcid.org/0000-0002-0762-0806
Bao, Erik L. http://orcid.org/0000-0002-6074-6766
Collins, Janine H. http://orcid.org/0000-0002-8716-3261
Downes, Kate
Grassi, Luigi http://orcid.org/0000-0002-6308-7540
Guerrero, Jose A. http://orcid.org/0000-0003-4307-6948
Kaptoge, Stephen
Knight, Julian C. http://orcid.org/0000-0002-0377-5536
Meacham, Stuart http://orcid.org/0000-0002-3667-6059
Sambrook, Jennifer
Seyres, Denis
Stegle, Oliver
Verboon, Jeffrey M.
Walter, Klaudia http://orcid.org/0000-0003-4448-0301
Watkins, Nicholas A.
Danesh, John
Roberts, David J.
Di Angelantonio, Emanuele
Sankaran, Vijay G. http://orcid.org/0000-0003-0044-443X
Frontini, Mattia http://orcid.org/0000-0001-8074-6299
Burgess, Stephen http://orcid.org/0000-0001-5365-8760
Kuijpers, Taco
Peters, James E. http://orcid.org/0000-0002-9415-3440
Butterworth, Adam S. http://orcid.org/0000-0002-6915-9015
Ouwehand, Willem H. http://orcid.org/0000-0002-7744-1790
Soranzo, Nicole http://orcid.org/0000-0003-1095-3852
Astle, William J. http://orcid.org/0000-0001-8866-6672
-
Funding
Funding for this research was provided by:
DH | National Institute for Health Research (NIHR BTRU-2014-10024)
British Heart Foundation (SP/09/002, RG/13/13/30194, RG/18/13/33946, FS/18/53/33863)
RCUK | Medical Research Council (MR/L003120/1)
- License Information
-
More Information
Article History
Received: 19 July 2021
Accepted: 7 August 2023
First Online: 18 August 2023
Competing interests
: P.A. is an employee of Regeneron Pharmaceuticals and receives salary from and owns options and/or stock of the company. The remaining authors declare no competing interests.
